Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease

12 Jan 2023

Abstract excerpt

OBJECTIVES: Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis (MDA5+DM), is susceptible to development of rapidly progressive interstitial lung disease (RPILD), which has been predominantly reported in East Asia. A Japanese genome-wide study has identified a WDFY4 variant rs7919656 linkage. We sought to evaluate this genetic marker and exploit its possible clinical relevance in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Immunodeficiency and Autoimmune Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammatory Myopathies and Dermatomyositis

Source

Identifiers

PMID: 36637178
DOI: 10.1093/rheumatology/kead006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung diseasePMID 36637178Read ↗

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.Semantic proximity Read ↗

The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases.Semantic proximity Read ↗

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.Semantic proximity Read ↗

Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population.Semantic proximity Read ↗

Correlation between lung microecology and immunity in patients with anti-MDA5 antibody-positive dermatomyositis combined with interstitial lung disease: protocol for a prospective, multicentre cohort studySemantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Treatment of Interstitial Lung Disease In Anti-MDA5-Positive Dermatomyositis: A Retrospective Study of 87 PatientsSemantic proximity Read ↗

Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.